Tonix Pharmaceuticals Holding Corp. Recorded Big Gain
Thu, Dec 19, 2024 at 07:10 PM
Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ) soared at $0.57, representing a gain of 56.3%. On Thu, Dec 19, 2024, TNXP:NASDAQ touched a New 2-Week High of $0.57. The stock got featured on our News Catalysts scanner on Tue, Dec 17, 2024 at 08:40 AM in the 'BIOTECH' category. From Thu, Dec 05, 2024, the stock recorded 80.00% Up Days and 45.45% Green Days
The stock spiked on Tue, Dec 17, 2024 at $1.3 with a volume of 984M+.
About Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ)
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 409.59%
- Nvni Group Limited (NVNI:NASDAQ), 317.19%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 122.72%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 92.42%
- Trio Petroleum Corp. (TPET:NYSEMKT), 79.16%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 64.56%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 60.78%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 56.25%
- Cara Therapeutics, Inc. (CARA:NASDAQ), 56.01%